LGND Operating Income Growth
Ligand Pharmaceuticals Inc · Operating Income Growth
LGND Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported394.55%period ending
LGND TTM Operating Income YoY % (33.97% → 394.55%)
Year-over-year change
High-resolution chart · PNG
LGND operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 394.5485% | |
| 263.0529% | |
| 308.7897% | |
| 207.3192% | |
| -109.041% | |
| -8,625.5172% | |
| -289.2983% | |
| -159.4228% | |
| -144.6174% | |
| -98.4699% | |
| -66.1815% | |
| -23.4012% | |
| -6.3617% | |
| -37.9075% | |
| -55.2412% | |
| -53.6384% | |
| -40.0177% | |
| 185.0441% | |
| 205.2583% | |
| 1,636.3106% | |
| 1,570.2405% | |
| 270.7507% | |
| -96.7977% | |
| -99.476% | |
| -100.5062% | |
| -101.6448% | |
| 392.9401% | |
| 435.0876% | |
| 478.0151% | |
| 904.4669% | |
| 140.5133% | |
| 169.0093% | |
| 216.4468% | |
| 140.781% | |
| 53.6902% | |
| 64.3183% | |
| 22.9423% | |
| 0.8676% | |
| 62.0851% | |
| 38.5617% | |
| 87.1618% | |
| 118.5836% | |
| 39.2317% | |
| 58.0749% | |
| 30.9033% | |
| 10.969% | |
| 31.3634% | |
| 27.1692% | |
| 87.3297% | |
| 205.5577% | |
| 2,498.4348% | |
| 575.4579% | |
| 5,230.1205% | |
| 599.2042% | |
| 182.2604% | |
| 115.425% | |
| 99.327% | |
| 102.7435% | |
| 97.6136% | |
| 43.8751% | |
| -338.4889% | |
| -313.0298% | |
| -194.5003% | |
| 73.9047% | |
| 93.8671% | |
| 92.8216% | |
| 89.7755% | |
| -164.9316% | |
| -167.4179% | |
| -115.4145% | |
| -61.6552% | |
| 32.4097% | |
| 35.9873% | |
| 14.2877% | |
| 61.9776% | |
| 71.1667% | |
| 64.816% | |
| 66.0329% | |
| -497.8694% | |
| -334.0345% | |
| -299.5199% | |
| -244.7277% | |
| 29.167% | |
| -155.6346% | |
| -99.827% | |
| -153.9988% | |
| -94.8741% | |
| 58.2516% | |
| 43.8343% | |
| 50.8831% | |
| 20.5954% | |
| -67.1819% | |
| -79.4273% | |
| -100.7653% | |
| -4.3826% | |
| 30.0327% | |
| 49.7064% | |
| 60.6907% | |
| 49.5728% | |
| 36.9208% |